Semler Scientific Investors File Class Action Lawsuit Over Alleged False Claims Act Violations
PorAinvest
viernes, 29 de agosto de 2025, 4:58 pm ET1 min de lectura
SMLR--
The Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit seeking damages for investors under the federal securities laws. The lawsuit claims that Semler Scientific failed to disclose a material investigation by the DOJ into alleged violations of the False Claims Act, while discussing potential violations in hypothetical terms. The firm asserts that these statements were materially false and misleading, causing investors to suffer damages when the true details emerged.
Investors who purchased Semler Scientific securities during the specified period are encouraged to contact the Rosen Law Firm to join the class action. The firm can be reached via their website, [Rosen Law Firm](https://rosenlegal.com/submit-form/?case_id=39889), by toll-free phone at 866-767-3653, or by email at case@rosenlegal.com. The deadline for individuals to serve as lead plaintiffs is October 28, 2025.
It is important to note that no class has yet been certified in this action. Investors are not represented by counsel unless they retain one. They may remain absent class members and take no action at this point. The ability to share in any potential future recovery is not dependent on serving as lead plaintiff.
References:
[1] Rosen Law Firm. (2025, August 29). Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors. Retrieved from https://www.businesswire.com/news/home/20250829361356/en/
Semler Scientific, Inc. is facing a class-action lawsuit for violating securities laws. Investors who purchased the company's securities between March 10, 2021, and April 15, 2025, are encouraged to contact the Schall Law Firm. The lawsuit alleges that Semler made false and misleading statements about a DOJ investigation into alleged violations of the False Claims Act.
Semler Scientific Inc. (NASDAQ: SMLR) is facing a class-action lawsuit filed by the Rosen Law Firm on behalf of investors who purchased the company's securities between March 10, 2021, and April 15, 2025. The lawsuit alleges that Semler Scientific made false and misleading statements regarding a Department of Justice (DOJ) investigation into potential violations of the False Claims Act.The Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit seeking damages for investors under the federal securities laws. The lawsuit claims that Semler Scientific failed to disclose a material investigation by the DOJ into alleged violations of the False Claims Act, while discussing potential violations in hypothetical terms. The firm asserts that these statements were materially false and misleading, causing investors to suffer damages when the true details emerged.
Investors who purchased Semler Scientific securities during the specified period are encouraged to contact the Rosen Law Firm to join the class action. The firm can be reached via their website, [Rosen Law Firm](https://rosenlegal.com/submit-form/?case_id=39889), by toll-free phone at 866-767-3653, or by email at case@rosenlegal.com. The deadline for individuals to serve as lead plaintiffs is October 28, 2025.
It is important to note that no class has yet been certified in this action. Investors are not represented by counsel unless they retain one. They may remain absent class members and take no action at this point. The ability to share in any potential future recovery is not dependent on serving as lead plaintiff.
References:
[1] Rosen Law Firm. (2025, August 29). Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors. Retrieved from https://www.businesswire.com/news/home/20250829361356/en/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios